Trends of ABC control 2006-2011: A National Survey of Diabetes Health Promotion Institutes in Taiwan

Diabetes Research and Clinical Practice

Volumn 99, Issue 2, 2013, Pages 112-119

  Yu, Neng Chun ^a   Su, Hsiu Yueh ^b   Chiou, Shu Ti ^c,d   Yeh, Mei Chang ^e   Yeh, Sheau Wen ^c   Tzeng, Min Su ^f   Sheu, Wayne H H ^d,g,h  

^a Yu Neng Chun Diabetes Clinic   (Taiwan)

^b TAIPEI MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^c DEPARTMENT OF HEALTH   (Taiwan)

^d NATIONAL YANG MING UNIVERSITY   (Taiwan)

^e NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^f FU JEN CATHOLIC UNIVERSITY   (Taiwan)

^g TAICHUNG VETERANS GENERAL HOSPITAL   (Taiwan)

^h NATIONAL DEFENSE MEDICAL CENTER   (Taiwan)

Author keywords

ABC control; Diabetes; Survey

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; ALPHA GLUCOSIDASE INHIBITOR; DIPEPTIDYL PEPTIDASE IV INHIBITOR; GLUCOSE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; METFORMIN; ORAL ANTIDIABETIC AGENT; SULFONYLUREA;

ADULT; ARTICLE; BLOOD PRESSURE REGULATION; BODY MASS; CLINICAL EXAMINATION; DIABETES CONTROL; DIASTOLIC BLOOD PRESSURE; DOWN REGULATION; FEMALE; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HEALTH PROGRAM; HEALTH PROMOTION; HEALTH SURVEY; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN TREATMENT; LIPID COMPOSITION; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; SYSTOLIC BLOOD PRESSURE; TAIWAN; TREND STUDY;

AGED; CHOLESTEROL; CHOLESTEROL, LDL; DIABETES MELLITUS, TYPE 2; FEMALE; HEALTH SURVEYS; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; MIDDLE AGED; TAIWAN;

EID: 84876697640     PISSN: 01688227     EISSN: 18728227     Source Type: Journal    
DOI: 10.1016/j.diabres.2012.11.018     Document Type: Article

References (28)

1. Gaede P., Lund-Andersen H., Parving H.H., Pedersen O. Effect of a multifactorial intervention on mortality in type 2 diabetes. N Engl J Med 2008, 358:580-591.
2. Chan J.C., So W.Y., Yeung C.Y., Ko G.T., Lau I.T., Tsang M.W., et al. Effects of structured versus usual care on renal endpoint in type 2 diabetes: the SURE study: a randomized multicenter translational study. Diabetes Care 2009, 32:977-982.
3. Tu S.T., Chang S.J., Chen J.F., Tien K.J., Hsiao J.Y., Chen H.C., et al. Prevention of diabetic nephropathy by tight target control in an Asian population with type 2 diabetes mellitus: a 4-year prospective analysis. Arch Intern Med 2010, 170:155-161.
4. IDF Clinical Guidelines Task Force Global guidelines for type 2 diabetes: recommendations for standard, comprehensive, and minimal care. Diabet. Med 2006, 23:579-593.
5. American Diabetes Association Standards of medical care in diabetes. Diabetes Care 2012, 35:S11-S63.
6. So W.Y., Raboca J., Sobrepena L., Yoon K.H., Deerochanawong C., Ho L.T., et al. Comprehensive risk assessments of diabetic patients from seven Asian countries: the Joint Asia Diabetes Evaluation (JADE) program. J Diabetes 2011, 3:109-118.
7. Chan J.C., Gagliardino J.J., Baik S.H., Chantelot J.M., Ferreira S.R., Hancu N., et al. Multifaceted determinants for achieving glycemic control: the International Diabetes Management Practice Study (IDMPS). Diabetes Care 2009, 32:227-233.
8. Saydah S.H., Fradkin J., Cowie C.C. Poor control of risk factors for vascular disease among adults with previously diagnosed diabetes. J Am Med Assoc 2004, 291:335-342.
9. Cheung B.M., Ong K.L., Cherny S.S., Sham P.C., Tso A.W., Lam K.S. Diabetes prevalence and therapeutic target achievement in the United States, 1999-2006. Am J Med 2009, 122:443-453.
10. Yu N.C., Su H.Y., Tsai S.T., Lin B.J., Shiu R.S., Hsieh Y.C., et al. ABC control of diabetes: survey data from the National Diabetes Health Promotion Centers in Taiwan. Diabetes Res Clin Pract 2009, 84:194-200.
11. Kong A.P., Yang X., Ko G.T., So W.Y., Chan W.B., Ma R.C., et al. Effects of treatment targets on subsequent cardiovascular events in Chinese patients with type 2 diabetes. Diabetes Care 2007, 30:953-959.
12. [accessed 13.06.12]. http://www.labmed.org.tw/.
13. Jiang Y.D., Shiu R.S., Chuang L.M., Lin B.J. Is the development of a diabetes care system important for quality care? An analysis in Taiwan. J Diab Invest 2011, 2:79-81.
14. Tai T.Y., Chuang L.M., Tsai S.T., Huang B.Y. Treatment of type 2 diabetes mellitus in a primary care setting in Taiwan: comparison with secondary/tertiary care. J Formos Med Assoc 2006, 105:105-117. Diabcare (Taiwan) Study Group.
15. Resnick H.E., Foster G.L., Bardsley J., Ratner R.E. Achievement of American Diabetes Association clinical practice recommendations among U.S. adults with diabetes, 1999-2002: the National Health and Nutrition Examination Survey. Diabetes Care 2006, 29:531-537.
16. Varma S., Boyle L.L., Varma M.R., Piatt G.A. Controlling the ABCs of diabetes in clinical practice: a community-based endocrinology practice experience. Diabetes Res Clin Pract 2008, 80:89-95.
17. Ekström N., Miftaraj M., Svensson A.M., Andersson Sundell K., Cederholm J., Zethelius B., et al. Glucose-lowering treatment and clinical results in 163,121 patients with type 2 diabetes: an observational study from the Swedish National Diabetes Register. Diabetes Obes Metab 2004, 10.1111/j.1463-1326.2012.01591.x.
18. Look AHEAD Research Group, Wing R.R. Long-term effects of a lifestyle intervention on weight and cardiovascular risk factors in individuals with type 2 diabetes mellitus: four-year results of the Look AHEAD trial. Arch Intern Med 2010, 170:1566-1575.
19. Ong K.L., Cheung B.M., Wong L.Y., Wat N.M., Tan K.C., Lam K.S. Prevalence, treatment, and control of diagnosed diabetes in the U.S. National Health and Nutrition Examination Survey 1999-2004. Ann Epidemiol 2008, 18:222-229.
20. Fharm E., Cederholm J., Eliasson B., Gudbjornsdottir S., Rolandsson O. Time trends in absolute and modifiable coronary heart disease risk in patients with type 2 diabetes in the Swedish National Diabetes Register (NDR) 2003-2008. Diabet Med 2012, 29:198-206.
21. Chang C.H., Shau W.Y., Jiang Y.D., Li H.Y., Chang T.J., Sheu W.H., et al. Type 2 diabetes prevalence and incidence among adults in Taiwan during 1999-2004: a national health insurance data set study. Diabet Med 2010, 27:636-643.
22. Lee T.T., Cheng S.H., Chen C.C., Lai M.S. A pay-for-performance program for diabetes care in Taiwan: a preliminary assessment. Am J Manage Care 2010, 16:65-69.
23. Cheng S.H., Lee T.T., Chen C.C. A longitudinal examination of a pay-for-performance program for diabetes care: evidence from a natural experiment. Med Care 2012, 50:109-116.
24. [accessed 13.06.12]. http://www.doh.gov.tw/CHT2006/DM/DM2_2.aspx%3Fnow_fod_list_no=11977%26class_no=440%26level_no=3.
25. Jensen T., Musaeus L., Molsing B., Lyholm B., Mandrup-Poulsen T. Process measures and outcome research as tools for future improvement of diabetes treatment quality. Diabetes Res Clin Pract 2002, 56:207-211.
26. Tseng F.Y., Lai M.S., Syu C.Y., Lin C.C. Professional accountability for diabetes care in Taiwan. Diabetes Res Clin Pract 2006, 71:192-201.
27. UK Prospective Diabetes Study (UKPDS) Group Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998, 352:837-853.
28. Fenton J.J., Von Korff M., Lin E.H., Ciechanowski P., Young B.A. Quality of preventive care for diabetes: effects of visit frequency and competing demands. Ann Fam Med 2006, 4:32-39.